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Phosphotyrosine phosphatase (PTPase) activity and its regu-
lation by overnight food deprivation were studied in Psammomys
obesus (sand rat), a gerbil model of insulin resistance and nutri-
tionally induced diabetes mellitus. PTPase activity was measured
using a phosphopeptide substrate containing a sequence identical
tothatofthemajorsiteofinsulinreceptor(IR)¯-subunitautophos-
phorylation. The PTPase activity in membrane fractions was 3.5-,
8.3-, and 5.9-fold lower in liver, fat, and skeletal muscle, respec-
tively, compared with corresponding tissues of albino rat. Western
blottingoftissuemembranefractionsinPsammomysshowedlower
PTPase and IR than in albino rats. The density of PTPase trans-
membrane protein band was 5.5-fold lower in liver and 12-fold
lower in adipose tissue. Leukocyte antigen receptor (LAR) and IR
were determined by speciﬁc immunoblotting and protein bands
densitometry and were also found to be 6.3-fold lower in the liver
and 22-fold lower in the adipose tissue in the hepatic membrane
fractions. Liver cytosolic PTPase activity after an overnight food
deprivation in the nondiabetic Psammomys rose 3.7-fold compared
with postprandial PTPase activity, but it did not change signiﬁ-
cantly in diabetic fasted animals. Similar fasting-related changes
were detected in the activity of PTPase derived from membrane
fraction. In conclusion, the above data demonstrate that despite
the insulin resistance, Psammomys is characterized by low level of
PTPaseactivitiesinmembraneandcytosolicfractionsinall3major
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insulin responsive tissues, as well as in liver. PTPase activity does
not rise in activity as a result of insulin resistance and nutritionally
induced diabetes.
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Insulin resistance is an innate characteristic of the gerbil
Psammomys obesus, also known as sand rat [1–3]. Muscle in-
sulin resistance in this desert-adapted animal saves the avail-
able food-derived glucose for use by glucose-dependent tissues.
The resistance is caused by impaired transduction of the signal
through the insulin receptor (IR) to the effector molecules in the
cell, associated with overexpression of protein kinase C (PKC)
isoenzymes in the skeletal muscle, particularly of PKC" [3, 4].
The IR tyrosine kinase (TK), although being activated by in-
sulin,autophosphorylatestheIRaswellasanumberofintracel-
lular proteins that further propagate the insulin signal. Phospho-
rylationoftyrosineresiduesontheIR¯-subunitintheregulatory
domain is critical for maintenance of its activity and, thus, for
proper transduction of the signal [5–7]. It has been previously
demonstrated that in Psammomys placed on high-energy diet,
the activation of TK by insulin is impaired [4]. In addition, the
overexpressed PKC isoenzymes exert a negative feedback on
the transduction of the insulin signal by phosphorylation of ser-
ine/threonine residues on IR and other effectors of the insulin
signaling pathway [8, 9].
One of the factors affecting the signal transduction is
the activity of protein tyrosine phosphatases (PTPases),
199200 J. MEYEROVITCH ET AL.
dephosphorylatingproteinsresidinginbothcytosolicandmem-
brane cell compartments [10, 11]. The down-regulating role of
PTPases in insulin-receptor cascade was demonstrated by ﬁnd-
ings of increased PTPase activity in tissues of animal models
of insulin-resistant obesity and type 2 diabetes, such as obese
fa/fa and diabetic ZDF/Drt-fa/fa rats [12, 13], and in human
obese subjects [14]. The obese humans demonstrated an in-
creaseinPTPaseleukocyteantigenreceptor(LAR)levelinsub-
cutaneous fat tissue where this enzyme was found responsible
for the elevated total PTPase activity in the membrane frac-
tion [14]. Further, insulin potentiation effect was evident by in-
hibitingPTPasesbyvanadateorPTPase-neutralizingantibodies
[15–19].
The Middle Eastern desert gerbil becomes diabetic within
a few weeks, when being fed a regular laboratory chow that
represents a high-energy diet, compared with its natural low-
calorie and ﬁber-rich salt-rich nourishment. The nutritionally
evoked diabetes develops through a number of stages. Nondia-
betic (fed a low-energy diet) Psammomys is considered as stage
A. Once placed on high-energy nutrition, the rodent develops
hyperinsulinemia (stage B), followed by marked nonfasting hy-
perglycemia (stage C) [2, 20]. Appearance of high postprandial
blood glucose levels is the hallmark for stage C in the course
of the disease. Such anomalous predisposition to diet-induced
diabetes mellitus is characteristic for most of the Psammomys
population, with the exception of a selectively inbred diabetes-
resistant line [21]. We wished, therefore, to investigate whether
an increase in PTPase activity in Psammomys might contribute
bothtotheinnateinsulinresistanceandthatinducedbyHEdiet.
MATERIALS AND METHODS
Materials
The IR ¯-subunit–related peptide, TRDIYETDYYRK, was
synthesized and puriﬁed in the Department of Organic Chem-
istry of the Weizmann Institute for Science (Rehovot, Israel).
Rabbit polyclonal antibodies raised to human LAR and to hu-
man IR ¯-subunit were supplied by the Transduction Labo-
ratories (Lexington, KY). Goat anti-rabbit immunoglobulin G
(IgG)–peroxidaseconjugate,proteaseinhibitors(aprotinin,ben-
zamidine, leupeptin, phenylmethylsulfonyl ﬂuoride [PMSF]),
HEPES, Tris, EDTA, NaCl, bovine serum albumin (BSA), ATP,
2-mercaptoethanol, detergents (Tween-20, Triton X-100), and
ion-exchangerDowex1£8–400allwerepurchasedfromSigma
(St. Louis, MO). 32P-labeled ATP was from DuPont (Boston,
MA). Acrylamide, N,N0-methylene-bis-acrylamide, sodium do-
decyl sulfate (SDS), ammonium persulfate, and TEMED were
from BioRad Laboratories (Richmond, CA). The nitrocel-
lulose membranes were from Schleicher & Schuel (Dassel,
Germany). Kits for enhanced chemoluminescence procedure
(ECL, Amersham, Little Chalfont, Buckinghamshire, England)
and for Bradford’s protein assay (BioRad), were used.
Animals
Seven to 8-week-old Psammomys obesus, weighing approx-
imately 100 g, from the Hebrew University colony (Jerusalem,
Israel)wereused.Theywereheldinseparatecagesandfedadli-
bitumwithspeciallow-calorienondiabetogenicnatural-likediet
of2.3cal/g[2](Koffolk,Petach-Tikva,Israel).Wistaralbinorats
(Harlan Labs) of the same age, weight, and gender, were used
as insulin-sensitive reference animals and fed a standard rodent
chow (Weizmann Institute). All rodents were normoglycemic,
asveriﬁedbycheckingbloodglucoselevelstwiceweekly.Toin-
duce the stage C hyperinsulinemia-hyperglycemia, 4-week-old
male Psammomys were placed on the diabetogenic high-energy
diet of 3 cal/g for 3 to 4 weeks until at least 2 consecutive non-
fasting glucose measurements revealed values of >300 mg/dL.
Animals, fasted overnight, were sacriﬁced by cervical disloca-
tion, between 8 and 9 AM. Specimens of liver, leg muscle, and
epididymal fat were excised, immediately frozen in liquid ni-
trogen, and stored at ¡80±C until processed. All experimental
procedures were authorized by the Institutional Animal Care
Committee.
Fractionation of Tissues
The preparation of membrane and cytosolic fractions of
liver, muscle, and fat was performed as described previously
[13, 16]. Brieﬂy, the tissues were homogenized, tissue particles
and unbroken cells were removed by low-speed centrifugation
(15 minutes at 600£g). The obtained supernatants were ultra-
centrifugedat180,000£gfor1houranddeﬁnedasthecytosolic
fraction. The resultant pellet was collected, resuspended with a
detergent (1% Triton X-100) for 1 hour, and ultracentrifuged
(180,000£g, 1 hour). The ﬁnal supernatant, containing the sol-
ubilized membrane proteins, was deﬁned as membrane, or par-
ticulate fraction. All procedures were performed at C4±Ci nt h e
presence of protease inhibitors.
Measurement of PTPase Activity
The PTPase assay was performed as described earlier [13,
22], using the IR-related synthetic phosphopeptide TRDIYET-
DYYRK, corresponding to amino acids 1142 to 1153 of IR
¯-subunit, as substrate. The phosphate released from the pep-
tide was separated from the other chemical forms of radioactive
phosphorus by means of organic extraction [23] and quantiﬁed
with the aid of ¯-radioactivity counter. The unit of PTPase ac-
tivity was deﬁned as picomoles phosphate released per minute
per milligram of tissue protein. The determination of total pro-
tein concentration in membrane fractions was performed by the
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Immunoblotting
The specimens of membrane fractions containing equal
amounts of total protein were run on 6% SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) under reducing conditions
and transferred onto nitrocellulose sheets. Unbound sites were
blocked using 1% BSA in 50 mM Tris, 150 mM NaCl, 0.05%
Tween-20, pH 7.4. Rabbit polyclonal anti-LAR or anti–IR
¯-subunit antibodies, diluted 1:125 in the blocking solution,
were used as primary antibodies. Anti-rabbit IgG-peroxidase
conjugate, diluted 1:10,000, was the secondary antibody. Incu-
bation with the antibodies was followed by intensive washing
with saline containing 0.05% Tween-20. Protein bands were vi-
sualizedusingECLdetectionsystem.Theintensityofthebands
was measured using optic densitometer Cliniscan 2 (Helena,
Beaumont, TX).
Statistical Analysis
Data are presented as means§SE. Groups were compared
by paired Student’s t test.
RESULTS
The PTPase activity in the membrane and cytosolic prepara-
tionsisshowninFigure1.Inall3majorinsulin-sensitivetissues,
the PTPase activity in both fractions was signiﬁcantly lower
in Psammomys compared with albino rats. In liver, the mem-
brane PTPase activity was 1.07§0.38 (nD8) and 3.76§0.85
(nD9,P<.001)unitsinPsammomysandinalbinorats,respec-
tively. In skeletal muscle membrane fraction, the activity was
0.17§0.02 (nD9) and 1.02§0.27 (nD7, P<.001) units in
Psammomysandinalbinorats,respectively.Inmembraneprepa-
rationsfromadiposetissue,theenzymeactivitywas0.35§0.11
and 2.92§0.91 units in Psammomys and in albino rats, respec-
tively (nD8, P<.001), whereas with cytosolic fraction the en-
zyme activity was 0.19§0.032 (nD8) and 1.13§0.12 (nD9,
P<.001) units in Psammomys and in albino rats, respectively.
In liver, the cytosolic PTPase activity was 0.31§0.1 (nD8)
and 1.51§0.5 (nD9, P<.001) units in Psammomys and in al-
binorats,respectively.Inskeletalmusclecytosolicpreparations,
the activity was 0.08§0.027 (nD9) and 0.36§0.046 (nD7,
P<.001) units in Psammomys and in albino rats, respectively.
In both animal species, the highest PTPase activity was found
in liver, and the lowest in muscle.
Figure 2 (upper panels) shows the immunoblots of liver and
fat tissue membrane fractions stained with speciﬁc antibodies
to the LAR transmembrane subunit. The immunoreactive bands
corresponding to the 85-kDa subunit were revealed in the tis-
sues of both rodent species. Optic densitometry showed a sig-
niﬁcantly lower strength of LAR bands, 5.5-fold lower in liver,
and 12-fold lower in fat.
FIGURE 1
PTPase activity in insulin responsive tissues of Psammomys
obesus and albino rats. (A) Cytosolic PTPase activity.
(B) Particulate fractions. Tissues of fasted overnight animals
were fractionated using isotonic sucrose differential
centrifugation. The particulate fraction was solubilized in
Triton X-100 1%. PTPase activity was assayed in cytosolic and
in particulate fractions. The PTPase assay was performed using
the IR-related synthetic phosphopeptide, corresponding to
amino acids 1142 to 1153 of IR ¯-subunit, as a substrate. The
phosphate released from the peptide was separated from the
other chemical forms of radioactive phosphorus by means of
organic extraction [22] and quantiﬁed with the aid of
¯-radioactivity counter. The results represent mean§SEM
of 7 to 9 animals in each group assayed in duplicate in 3
separate experiments. ¤P<.01.
PTPase LAR has been demonstrated to have a high activity
towards the IR ¯-subunit. For this reason, we assessed the rela-
tive amount of the ¯-subunits of the IR using immunostaining.
The membrane fraction preparations were run on SDS-PAGE,
blotted, and immunostained with anti–IR ¯-subunit antibod-
ies. The Western blot demonstrated the immunoreactive 97-kDa
¯-subunit polypeptides (Figure 2, lower panels) in samples
from both Psammomys and albino rat. The intensity of the IR
¯-subunit bands were signiﬁcantly (6.3 fold) lower in Psam-
momys liver than in the liver of albino rats. In fat, the inten-
sity of these bands was 22 fold lower, thus, the PTPase per IR
¯-subunit ratio increased especially in the fat tissue.202 J. MEYEROVITCH ET AL.
FIGURE 2
PTPase LAR immunoblotting and insulin receptor ¯-subunit in tissues of Wistar rat and Psammomys obesus. Membrane
fractions of hepatic and adipose tissues from either species were resolved on SDS/PAGE, transferred onto nitrocellulose paper,
and blotted with anti-LAR antibody (panels A and B) and with anti–IR ¯-subunit antibody (panels C and D). Panels A and C,l i v e r
tissue (50 ¹g/lane); panels B and D, fat tissue (100 ¹g/lane). Lanes 1, Wistar rat; lanes 2, Psammomys obesus; lanes 3, positive
controls for each antibody; letters a and b refer to duplicates.
LARPTPaseandIRlevelsinhepaticmembranefractionsob-
tained from nondiabetic Psammomys obesus and the diabetes-
pronesublineweresimilartothoseobtainedfromdiabeticPsam-
momysandfromtheinbreddiabetes-resistantPsammomys(data
not shown).
An important feature of the nutritionally induced diabetes in
Psammomys obesus is the low hepatic glucose production dur-
ing food deprivation. Thus, we studied the regulation of PTPase
FIGURE 3
Effect of overnight food deprivation on PTPase activity of
cytosolic fraction of the hepatic tissue in prediabetic and
diabetic Psammomys obesus. Liver fractionation and PTPase
assay as described in Materials and Methods. The results
represent mean§SEM of 9 animals in each group assayed in
duplicate. ¤P<.05.
activityafterfasting.ThehepaticcytosolicPTPaseactivityinthe
normoglycemic(stageA)Psammomyswas0.09§0.025unitsin
thefedsubgroup,but0.33§0.09unitsinthefood-deprivedsub-
group,thatis,a3.7-fold(nD8, P <.04)increasewasobserved.
Contrary to this, in the diabetic (stage C) group, the changes
after overnight fasting were in the same direction but did not
reach statistical signiﬁcance (0.15§0.09 and 0.26§0.08 units,
respectively, Figure 3).
DISCUSSION
Psammomysobesus,arodentmodelofinsulinresistanceand
nutritionally induced diabetes, has been found to have low PT-
Pase activity in both cytosolic and particulate fractions of liver,
muscle, and fat, the 3 major insulin-responsive tissues. Psam-
momys also exhibits a low level of the receptor-type PTPase
LAR in hepatic and adipose tissues. Low PTPase activity (in
comparison with albino rat tissues) should be considered a
species characteristics of Psammomys obesus in parallel with
thelowTKactivityinmuscleandliverofthisgerbil,asreported
previously [4].
Previous studies regarding PTPase activities, using vari-
ous substrates and different insulin-resistant states in several
genetically diabetic animals, yielded divergent results. In the
obese fa/fa and diabetic ZDF/Drt-fa/fa rats, an increased in
activity of PTPases LAR and PTP 1B, as well as of the SH
domain–containing PTPase (SH-PTP2), were found [25, 26].
In mice with type 2–like diabetes, a reduced PTPase activity in
bothcytosolicandparticulatefractionswasfoundusingthesame
enzymatic assay [16]. In human subjects, the basal particulate
PTPaseactivitywas33%higherininsulin-resistantsubjectsthan
ininsulin-sensitivesubjects[25],whereasKusariandcolleaguesPTPase ACTIVITY IN PSAMMOMYS OBESUS 203
reported reduced muscle PTPase activity in obese nondiabetic
and type 2 diabetic subjects [26].
The lack of contribution of PTPase activity to insulin resis-
tance of Psammomys could be attributed to several reasons: A
primary defect in the translation or stability of the protein was
not proved in this model. The phenotypic characteristic of the
homozygous PTPase (¡/¡) mice with increased insulin sen-
sitivity, and lower plasma levels of insulin and glucose, also
do not support a primary defect in the expression of PTPase.
Thedown-regulatingofPTPaseandcytosolicPTPasesecondary
todown-regulationoftheIRinhyperinsulinemicstateisanother
possible mechanism. However, because there is a reduced level
of the IR in the Psammomys [4], the ratio of PTPase to the IR
does not decrease, or is even increased (in the fat tissue). Thus,
the actual steady state of the tyrosine phosphorylation and de-
phosphorylation may be reduced. The effect of treatment on
the Psammomys by vanadyl sulphate [27], resulting in reduced
blood glucose levels, may indicate that a relative inappropriate
overactivity of PTPase is operative in the Psammomys.
Inourstudy,wedemonstratedthelowIRlevelinPsammomys
obesus using an immunoblot technique. The low number of IR
wasalsoshownbyKanetyandcolleagues[4]byinsulinbinding
studies. We presume that the low level of IR may render an
animal prone to insulin resistance, or it may be secondary to the
chronic hyperinsulinemic state characteristic of this phenotype,
when maintained on a high-energy diet [1, 2].
With regard to PTP 1B, it was recently found that the ex-
pression of this enzyme was elevated in diabetic Psammomys;
however, PTP 1B speciﬁc activity (activity/protein) was signif-
icantly decreased in skeletal muscle of diabetic Psammomys
compared with both the diabetes-resistant line and nondiabetic
animals [28]. PTP 1B activity, as well as total PTPase activity,
was inversely correlated to serum glucose level, which suggests
that PTP 1B, though overexpressed, was attenuated by hyper-
glycemia or other factors in the diabetic milieu.
Starvation was shown to reduce the activity of liver cytosolic
PTPase. Acute regulation of PTPases has also been demon-
strated in a hepatoma cell line [29]. However, the diabetic state
was associated with poor response of the cytosolic PTPase to
fasting, indicating that impaired insulin action is accompanied
by change in activity of the enzyme, possibly by a regulatory
defect.
The physiologic role of hepatic PTPase may be important
in association with hepatic gluconegenesis. Ziv and colleagues
[1] found that insulin failed to suppress the hepatic gluconeo-
genesis in nondiabetic Psammomys administered with exter-
nal insulin. We have demonstrated that vanadate administration
suppresses liver gluconeogenesis in the diabetic state of NOD
mice, and PTPase may have a role in this metabolic pathway
[30].
Inconclusion,ourdatademonstratethattheinsulinresistance
of Psammomys, a desert gerbil surviving on scant nutrition, is
characterized by low level of PTPase activity in the membrane
and cytosolic fractions in all 3 major insulin-responsive tissues,
and an increased response to overnight food deprivation. How-
ever, the effect of fasting is lacking in diabetic, insulin-resistant
animals. This observation suggests that total PTPase activity
does not attenuate IR phosphorylation and its suppression and
may serve as an important target for treating the nutritionally
induced insulin-resistant state.
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